PharmAla Biotech To Supply University Of Texas, San Antonio For Clinical Trial
PharmAla Biotech will supply the University of Texas, San Antonio with a novel LaNeo MDMA dosage form for a clinical trial, ...
PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA
Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, ...
Le Lézard9h
QCI and Context Networks Partner to Explore a New Revenue Stream in the Digital Marketplace
Quick Custom Intelligence (QCI), a leading provider of data activation solutions for the gaming and hospitality industries, today announced a reactivation of its partnership with Context Networks to ...
Le Lézard9h
Talkiatry Expands Postpartum Depression Care Services to Close Gaps in Maternal Mental Healthcare
Approximately one in eight U.S. women report experiencing postpartum depression symptoms 1 yet care pathways remain complex, leading to delayed diagnosis and treatment; Talkiatry ...
greenmarketreport6d
PharmAla Biotech to supply MDMA for Harvard med school clinical trial
The company says it's currently the only supplier of clinical-grade MDMA for patient treatments outside of clinical trials.
PharmAla to supply Harvard Medical School trial with MDMA
PharmAla Biotech (CSE:MDMA) has been contracted as a supplier of MDMA to a clinical trial at Harvard’s Maclean Hospital ・The ...
PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMA
Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...